202 related articles for article (PubMed ID: 37581672)
1. Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring: The MAGENTA Randomized Clinical Trial.
Crowther CA; Ashwood P; Middleton PF; McPhee A; Tran T; Harding JE;
JAMA; 2023 Aug; 330(7):603-614. PubMed ID: 37581672
[TBL] [Abstract][Full Text] [Related]
2. Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.
Crowther CA; Middleton PF; Wilkinson D; Ashwood P; Haslam R;
BMC Pregnancy Childbirth; 2013 Apr; 13():91. PubMed ID: 23570677
[TBL] [Abstract][Full Text] [Related]
3. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
[TBL] [Abstract][Full Text] [Related]
4. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
Crowther CA; Hiller JE; Doyle LW; Haslam RR;
JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
[TBL] [Abstract][Full Text] [Related]
5. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Magnesium supplementation in pregnancy.
Makrides M; Crosby DD; Bain E; Crowther CA
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD000937. PubMed ID: 24696187
[TBL] [Abstract][Full Text] [Related]
8. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
[TBL] [Abstract][Full Text] [Related]
9. Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes.
McPherson JA; Rouse DJ; Grobman WA; Palatnik A; Stamilio DM
Obstet Gynecol; 2014 Oct; 124(4):749-755. PubMed ID: 25198275
[TBL] [Abstract][Full Text] [Related]
10. Working to improve survival and health for babies born very preterm: the WISH project protocol.
Crowther CA; Middleton PF; Bain E; Ashwood P; Bubner T; Flenady V; Morris J; McIntyre S;
BMC Pregnancy Childbirth; 2013 Dec; 13():239. PubMed ID: 24354790
[TBL] [Abstract][Full Text] [Related]
11. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial.
Wolf HT; Brok J; Henriksen TB; Greisen G; Salvig JD; Pryds O; Hedegaard M; Weber T; Hegaard HK; Pinborg A; Huusom LD;
BJOG; 2020 Sep; 127(10):1217-1225. PubMed ID: 32237024
[TBL] [Abstract][Full Text] [Related]
12. Vaginal progesterone pessaries for pregnant women with a previous preterm birth to prevent neonatal respiratory distress syndrome (the PROGRESS Study): A multicentre, randomised, placebo-controlled trial.
Crowther CA; Ashwood P; McPhee AJ; Flenady V; Tran T; Dodd JM; Robinson JS;
PLoS Med; 2017 Sep; 14(9):e1002390. PubMed ID: 28949973
[TBL] [Abstract][Full Text] [Related]
13. Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).
Lorthe E; Torchin H; Delorme P; Ancel PY; Marchand-Martin L; Foix-L'Hélias L; Benhammou V; Gire C; d'Ercole C; Winer N; Sentilhes L; Subtil D; Goffinet F; Kayem G
Am J Obstet Gynecol; 2018 Sep; 219(3):298.e1-298.e14. PubMed ID: 29852153
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.
Rouse DJ; Hirtz DG; Thom E; Varner MW; Spong CY; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Alexander JM; Harper M; Thorp JM; Ramin SM; Malone FD; Carpenter M; Miodovnik M; Moawad A; O'Sullivan MJ; Peaceman AM; Hankins GD; Langer O; Caritis SN; Roberts JM;
N Engl J Med; 2008 Aug; 359(9):895-905. PubMed ID: 18753646
[TBL] [Abstract][Full Text] [Related]
15. Prenatal Tobacco Exposure and Childhood Neurodevelopment among Infants Born Prematurely.
Robbins LS; Blanchard CT; Sinkey RG; Harris SL; Tita AT; Harper LM
Am J Perinatol; 2021 Feb; 38(3):218-223. PubMed ID: 32862421
[TBL] [Abstract][Full Text] [Related]
16. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.
Walters A; McKinlay C; Middleton P; Harding JE; Crowther CA
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD003935. PubMed ID: 35377461
[TBL] [Abstract][Full Text] [Related]
17. Prenatal Magnesium Sulfate and Functional Connectivity in Offspring at Term-Equivalent Age.
Ufkes S; Kennedy E; Poppe T; Miller SP; Thompson B; Guo J; Harding JE; Crowther CA
JAMA Netw Open; 2024 May; 7(5):e2413508. PubMed ID: 38805222
[TBL] [Abstract][Full Text] [Related]
18. Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews.
Shepherd E; Salam RA; Middleton P; Makrides M; McIntyre S; Badawi N; Crowther CA
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012077. PubMed ID: 28786098
[TBL] [Abstract][Full Text] [Related]
19. Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.
Stock SJ; Bricker L; Norman JE; West HM
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008968. PubMed ID: 27404120
[TBL] [Abstract][Full Text] [Related]
20. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis.
Costantine MM; Weiner SJ;
Obstet Gynecol; 2009 Aug; 114(2 Pt 1):354-364. PubMed ID: 19622997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
